North America Cell And Gene Therapy Cdmo Market Size & Outlook

Name: North America Cell And Gene Therapy Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cell and gene therapy cdmo market in North America is expected to reach a projected revenue of US$ 10,984.9 million by 2033. A compound annual growth rate of 22.9% is expected of North America cell and gene therapy cdmo market from 2025 to 2033.

HC Outsourcing
- CMO/CDMO
  - Cell And Gene Therapy CDMO Market Outlook

North America cell and gene therapy cdmo phase outlook (Revenue, USD million, 2021-2033)
- Pre-clinical
- Clinical
North America cell and gene therapy cdmo indication outlook (Revenue, USD million, 2021-2033)
- Rare Diseases
- Others
- Oncology
- Infectious Diseases
- Neurological disorders
North America cell and gene therapy cdmo product type outlook (Revenue, USD million, 2021-2033)
- Gene Therapy
  - Ex-vivo
  - In-vivo
- Gene-Modified Cell Therapy
  - CAR T-cell therapies
  - TCR-T cell therapy
  - Other
  - CAR-NK cell therapy
- Cell Therapy

North America Cell And Gene Therapy Cdmo Market Size & Outlook

Data Tree

Sign up - it's easy, and free!